docetaxel anhydrous has been researched along with Mouth Neoplasms in 74 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.35) | 18.2507 |
| 2000's | 17 (22.97) | 29.6817 |
| 2010's | 42 (56.76) | 24.3611 |
| 2020's | 14 (18.92) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, S; Chaturvedi, P; Chaukar, D; D'Cruz, A; Deshmukh, A; Ghosh-Laskar, S; Nair, D; Nair, S; Noronha, V; Pai, PS; Pantvaidya, G; Patil, A; Patil, VM; Prabash, K; Rane, P; Sharma, S; Thiagarajan, S; Vaish, R | 1 |
| Dong, MJ; Fu, JY; Li, J; Yue, XH; Zhang, CP | 1 |
| Khamaikawin, W; Locharoenrat, K | 1 |
| Chen, X; Hata, M; Hayashi, Y; Kioi, M; Koike, I; Koizumi, T; Mitsudo, K; Yamanaka, S | 1 |
| Hayashi, Y; Hibi, H; Sato, K; Watanabe, K; Yoshimi, R | 1 |
| Ju, WT; Liang, SY; Liu, Y; Tan, YR; Zhang, CP; Zhang, ZY; Zhao, TC; Zhong, LP; Zhu, DW | 1 |
| Ju, WT; Li, J; Liang, SY; Ma, HL; Wang, LZ; Zhang, ZY; Zhao, TC; Zhong, LP; Zhou, G; Zhu, DW | 1 |
| Endo, M; Hasegawa, H; Kaneko, T; Kanno, C; Kano, M; Kitabatake, T; Monma, T; Sato, E; Takeishi, E; Yamazaki, M | 1 |
| Dou, S; Jiang, W; Li, R; Sun, J; Zhang, C; Zhong, L; Zhu, G | 1 |
| Hashemy, I; Masood, AI; Shah, SIH; Zaidi, SHM | 1 |
| Chen, Q; Dai, Y; Liu, R; Wen, J; Xu, H; Xu, Y | 1 |
| Baste, N; Berrocal-Jaime, A; Cruz-Hernández, JJ; Cunquero-Tomas, AJ; Del Barco-Morillo, E; García-Girón, C; Grau, JJ; Guix, M; Hitt, R; Iglesias, L; Lambea-Sorrosal, J; León-Vintró, X; López-Pousa, A; Martínez-Trufero, J; Ocaña, A | 1 |
| He, Y; Hu, YJ; Ji, T; Ju, WT; Li, J; Liu, Y; Ren, GX; Sun, J; Tu, WY; Wang, LZ; Wang, YA; Yang, WJ; Zhang, CP; Zhang, ZY; Zhong, LP | 1 |
| Aladelusi, TO; Ju, W; Sun, W; Zhang, Z; Zhao, T; Zhong, L; Zhu, D | 1 |
| Murodumi, H; Ohta, K; Ono, S; Sakuma, M; Shigeishi, H; Takechi, M; Tobiume, K; Yokoyama, S | 1 |
| Chang, PM; Chen, MH; Chu, PY; Lu, HJ; Tai, SK; Wang, LW; Yang, MH | 1 |
| Dietz, A; Görner, M; Grosse-Thie, C; Guntinas-Lichius, O; Inhestern, J; Jungehülsing, M; Kuhnt, T; Maschmeyer, G; Rotter, N; Schmalenberg, H; Sudhoff, H; Wittekindt, C | 1 |
| Ando, H; Fujimura, A; Hayasaka, JI; Jinbu, Y; Kusama, M; Mori, Y; Noguchi, T; Okada, N; Tsuchiya, Y; Ushijima, K | 1 |
| Belz, J; Dwivedi, PD; Gupta, P; Kumar, R; Shanker, R; Singh, M; Singh, SP; Sridhar, S | 1 |
| Hata, M; Hayashi, Y; Hirota, M; Iida, M; Iwai, T; Kioi, M; Koike, I; Koizumi, T; Mitsudo, K; Nozato, T; Oguri, S; Tohnai, I | 1 |
| Chen, Q; Wang, X; Wei, KJ; Yu, YC | 1 |
| Bacay, A; Bakst, RL; Catalano, PJ; Chau, NG; Gupta, V; Haddad, RI; Hanna, GJ; Mahmood, U; Margalit, DN; McHugh, P; Misiukiewicz, KJ; Posner, M; Rabinowits, G; Rath, L; Rawal, B; Schoenfeld, JD; Tishler, RB | 1 |
| Lee, JJ; Li, J; Liu, Y; Ma, J; Myers, JN; Wang, LZ; William, WN; Yang, CZ; Yang, X; Zhang, CP; Zhang, ZY; Zhong, LP; Zhu, DW | 1 |
| Wang, B; Wang, XD; Yue, K; Zhang, S | 1 |
| Gu, QP; Guo, W; Li, ZP; Meng, J; Meng, QF; Si, YM; Zhang, J; Zhuang, QW | 1 |
| Guo, W; Li, C; Lyu, J; Ren, G; Wang, R; Wu, Y | 1 |
| Li, J; Liu, Y; Ma, J; Montgomery, B; Wang, LZ; Yang, CZ; Zhang, CP; Zhang, ZY; Zhong, LP; Zhu, DW | 1 |
| Hata, M; Hirota, M; Iida, M; Iwai, T; Kioi, M; Koike, I; Koizumi, T; Mitsudo, K; Nakashima, H; Oguri, S; Tohnai, I | 1 |
| Jin, J; Li, RX; Liu, SH; Wang, LP; Wang, Y; Ye, MC; Zhou, Y; Zhu, WZ; Zuo, Y | 1 |
| Hoshikawa, H; Indo, K; Kamitori, K; Mori, N; Mori, T; Tokuda, M; Yamaguchi, F | 1 |
| Agüero, A; Farré, N; García, J; León, X; López, M; López-Pousa, A; Quer, M | 1 |
| Hanai, N; Hasegawa, Y; Hirakawa, H; Nakashima, T; Nishikawa, D; Ozawa, T; Suzuki, H | 1 |
| Ding, X; Geng, M; Huang, M; Li, H; Sun, W; Wu, H; Xie, Z; Zhang, X | 1 |
| Aghili, M; Garajei, A; Harirchi, I; Kazemian, A; Keyhani, A; Motiee Langroudi, M; Nikparto, N; Sadighi, S; Zendehdel, K | 1 |
| Choi, SH; Kim, JH; Kim, SC; Ryoo, I; Sohn, CH | 1 |
| Cai, YL; Guo, W; He, Y; Hong, CS; Hu, YJ; Ji, T; Lee, JJ; Li, J; Myers, JN; Ren, GX; Sun, J; Tu, WY; Wang, LZ; Wang, YA; Wang, ZH; William, WN; Xu, LQ; Yang, WJ; Ye, WM; Yin, QM; Zhang, CP; Zhang, ZY; Zhong, LP; Zhu, HG; Zhuang, Z | 1 |
| Arya, S; Bhattacharjee, A; D'Cruz, A; Dhumal, S; Joshi, A; Juvekar, S; Kane, S; Muddu, V; Noronha, V; Patil, VM; Prabhash, K | 1 |
| Iwasaki, K; Mitomo, K; Nakayama, S; Tamate, S; Uchiyama, K; Yamada, M | 1 |
| Ferdous, T; Harada, K; Harada, T; Ueyama, Y | 1 |
| Hiraiwa, T; Koike, M; Okada, H; Senda, N; Suzuki, K | 1 |
| Chan, KK; Furness, S; Glenny, AM; Wakeford, H; Weldon, JC; Worthington, HV | 1 |
| Azami, Y; Fuwa, N; Hareyama, M; Hatayama, Y; Hayashi, Y; Kikuchi, Y; Mitsudo, K; Nakamura, T; Ono, T; Suzuki, M; Takayama, K; Tohnai, I; Tsukiyama, I; Yamaguchi, H | 1 |
| Qiu, L; Yu, Y | 1 |
| Banavali, SD; Joshi, A; Muddu, V; Noronha, V; Patil, VM; Prabhash, K | 1 |
| Alfieri, S; Bergamini, C; Bossi, P; Cavallo, A; Cova, A; Granata, R; Huber, V; Iacovelli, NA; Imbimbo, M; Licitra, L; Locati, L; Mariani, L; Miceli, R; Orlandi, E; Resteghini, C; Rivoltini, L | 1 |
| Harada, K; Horinaga, D; Mano, T; Mihara, M; Okafuji, M; Uchida, K; Ueyama, Y; Wada, N | 1 |
| Fouret, P; Handra-Luca, A; Planchard, D | 1 |
| Furuta, I; Kurashina, K; Kurita, H; Miyata, M; Nozaki, S; Wada, S; Yamamoto, E | 1 |
| Kakehata, S; Kimura, H; Kobayashi, W; Nagahata, M; Sakaki, H; Sato, H; Teh, BG | 1 |
| Alieva, SB; Romanov, IS; Tiuliandin, SA; Tkachev, SI; Zaderenko, IA | 1 |
| Fujisawa, K; Iwamoto, S; Miyamoto, Y; Nagai, H; Ohe, G; Takamaru, N; Tamatani, T; Uchida, D | 1 |
| Asahina, I; Ikeda, H; Ikeda, M; Kawasaki, T; Shiraishi, T; Tajima, N; Uehara, M | 1 |
| Hirota, M; Iida, M; Itoh, Y; Iwai, T; Kioi, M; Koizumi, T; Mitsudo, K; Oguri, S; Tohnai, I; Yamamoto, N | 1 |
| Ferdous, T; Fujisawa, K; Hara, K; Kinouchi, M; Kuribayashi, N; Miyamoto, Y; Nagai, H; Ohe, G; Takamaru, N; Tamatani, T; Uchida, D | 1 |
| Dietz, A; Guntinas-Lichius, O; Kuhnt, T; Maschmeyer, G; Oertel, K; Schmalenberg, H; Spiegel, K; Sudhoff, H; Wendt, TG | 1 |
| Larizadeh, MH; Shabani, M | 1 |
| Cai, YL; Fan, XD; Guo, W; He, Y; Hu, YJ; Ji, T; Kies, MS; Lee, JJ; Li, J; Myers, JN; Ren, GX; Sun, J; Tu, WY; Wang, BS; Wang, LZ; Wang, YA; Wang, ZH; William, WN; Xu, LQ; Yang, WJ; Ye, WM; Zhang, CP; Zhang, ZY; Zhong, LP; Zhu, HG | 1 |
| Aota, K; Azuma, M; Harada, M; Kani, K; Momota, Y; Motegi, K; Takano, H; Yamamura, Y; Yamanoi, T | 1 |
| Hamakawa, H; Hino, S; Nakashiro, KI; Shintani, S; Terakado, N | 1 |
| Furuta, I; Kurashina, K; Kurita, H; Nozaki, S; Wada, S; Yamamoto, E | 1 |
| Echigo, S; Rikiishi, H; Sato, T; Shinohara, F; Takahashi, M; Taniguchi, T | 1 |
| Asaumi, J; Fukui, K; Kawai, N; Kishi, K; Kokeguchi, S; Kuroda, M; Maki, Y; Matsubara, N; Murakami, J; Nagatsuka, H; Tanaka, N; Tsujigiwa, H; Yanagi, Y | 1 |
| Komatsubara, H; Komori, T; Minamikawa, T; Ojima, Y; Shibuya, Y; Shigeta, T; Umeda, M; Yokoo, S | 1 |
| Akino, K; Hiratsuka, H; Imai, K; Kashima, L; Mita, H; Nishikawa, N; Noguchi, M; Ogi, K; Sasaki, Y; Satoh, A; Shinomura, Y; Suzuki, H; Tokino, T; Toyota, M | 1 |
| Akagi, H; Kariya, S; Kosaka, M; Nishizaki, K; Orita, Y | 1 |
| Fukuda, M; Hatakeyama, S; Kashiwagi, R; Miyamoto, Y; Miyoshi, K; Murayama, D; Musashi, T; Nagai, H; Nanjo, H; Ohnuki, T; Yamaoka, K | 1 |
| Kovács, AF | 1 |
| Eberlein, K; Kovács, AF; Rohde, S; Smolarz, A; Weidauer, S | 1 |
| Tohnai, I | 1 |
| Bidault, F; Casiraghi, O; De Baere, T; Faivre, S; Janot, F; Kuoch, V; Luboinski, B; Petrow, P; Roche, A; Sigal, R; Temam, S | 1 |
| Abe, M; Dehari, H; Hiratsuka, H; Kido, Y; Kobayashi, J; Miyazaki, A; Nagai, I; Nakamori, K; Takemura, K; Tomihara, K; Yamamoto, T | 1 |
| Fukuda, M; Ito, H; Iwanami, Y; Miyamoto, Y; Nagai, H; Nakata, A; Nanjo, H; Takano, H | 1 |
| Eckardt, A; Fokas, K; Haindl, J; Hüttmann, C | 1 |
| Kovács, AF; Schiemann, M; Turowski, B | 1 |
3 review(s) available for docetaxel anhydrous and Mouth Neoplasms
| Article | Year |
|---|---|
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Docetaxel; ErbB Receptors; Gefitinib; Humans; Immunotherapy; Lapatinib; Molecular Targeted Therapy; Mouth Neoplasms; Oropharyngeal Neoplasms; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Quinazolines; Randomized Controlled Trials as Topic; Taxoids | 2015 |
Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral Cancers.
Topics: Administration, Metronomic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Mouth Neoplasms; Neoadjuvant Therapy; Preoperative Care; Taxoids | 2016 |
Chemotherapy using intra-arterial infusion for oral cancer.
Topics: Antineoplastic Agents; Cisplatin; Docetaxel; Femoral Artery; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Taxoids; Temporal Arteries; Tongue Neoplasms | 2006 |
24 trial(s) available for docetaxel anhydrous and Mouth Neoplasms
| Article | Year |
|---|---|
Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Cisplatin; Disease Progression; Docetaxel; Female; Fluorouracil; Humans; India; Male; Mandible; Mandibular Osteotomy; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Progression-Free Survival; Prospective Studies; Squamous Cell Carcinoma of Head and Neck; Time Factors; Tumor Burden | 2022 |
Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Body Mass Index; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Treatment Outcome | 2020 |
Stathmin guides personalized therapy in oral squamous cell carcinoma.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Male; Mice; Middle Aged; Mouth Neoplasms; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Precision Medicine; Signal Transduction; Stathmin; Taxoids; TOR Serine-Threonine Kinases | 2020 |
A Phase 2 Trial of Chemoradiation Therapy Using Weekly Docetaxel for High-Risk Postoperative Oral Squamous Cell Carcinoma Patients.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Docetaxel; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Postoperative Period; Risk; Safety; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2020 |
Phase III trial of docetaxel cisplatin 5-fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Mouth Neoplasms; Treatment Outcome | 2021 |
Effectiveness of incorporating cetuximab into docetaxel/cisplatin/fluorouracil induction chemotherapy and chemoradiotherapy for inoperable squamous cell carcinoma of the oral cavity: A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Prospective Studies; Survival Analysis; Taxoids; Treatment Outcome | 2017 |
A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patien
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Deglutition; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Oropharyngeal Neoplasms; Postoperative Care; Quality of Life; Survival Analysis; Taxoids | 2017 |
A Phase 1 Study of Afatinib in Combination with Postoperative Radiation Therapy with and Without Weekly Docetaxel in Intermediate- and High-Risk Patients with Resected Squamous Cell Carcinoma of the Head and Neck.
Topics: Adult; Afatinib; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Diarrhea; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Hypokalemia; Male; Maximum Tolerated Dose; Middle Aged; Mouth Neoplasms; Mucositis; Postoperative Period; Prospective Studies; Radiotherapy Dosage | 2019 |
Efficacy of nimotuzumab combined with docetaxel-cisplatin-fluorouracil regimen in treatment of advanced oral carcinoma.
Topics: Aged; Aged, 80 and over; Alopecia; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carcinoma; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Injections, Intravenous; Male; Middle Aged; Mouth Neoplasms; Nausea; Neoplasm Staging; Taxoids; Treatment Outcome | 2014 |
GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinogenesis; Carcinoma, Squamous Cell; Cisplatin; Disease Progression; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Growth Differentiation Factor 15; Humans; Immunohistochemistry; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Taxoids | 2014 |
[Grade IV myelosuppression after induction chemotherapy of TPF on oral cancer: clinical analysis of 29 cases].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Mouth Mucosa; Mouth Neoplasms; Retrospective Studies; Taxoids | 2014 |
Neoadjuvant Chemotherapy for Locally Advanced Squamous Carcinoma of Oral Cavity: a Pilot Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Pilot Projects; Taxoids; Young Adult | 2015 |
Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prospective Studies; Radiotherapy; Surgical Procedures, Operative; Taxoids; Treatment Outcome; Young Adult | 2015 |
[Clinical phase I trial of S-1 in the combination with DOC using super-selective intra-arterial infusion with oral cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Dose-Response Relationship, Drug; Drug Combinations; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Oxonic Acid; Taxoids; Tegafur | 2009 |
Multicenter phase 2 study of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
Topics: Adult; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Diarrhea; Docetaxel; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Neutropenia; Organoplatinum Compounds; Prospective Studies; Taxoids; Treatment Outcome; Young Adult | 2010 |
Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoplasm Grading; Neoplasm Staging; Oropharyngeal Neoplasms; Taxoids; Treatment Outcome | 2012 |
Survival following non surgical treatments for oral cancer: a single institutional result.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Prognosis; Survival Rate; Taxoids; Turkey | 2012 |
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Hematologic Diseases; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Mucositis; Nausea; Prospective Studies; Radiotherapy; Taxoids; Treatment Outcome | 2013 |
Multicenter phase I trial of induction chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mouth Neoplasms; Organoplatinum Compounds; Remission Induction; Taxoids; Treatment Outcome | 2004 |
Lack of survival advantage in patients with advanced, resectable squamous cell carcinoma of the oral cavity receiving induction chemotherapy with cisplatin (CDDP), docetaxel (TXT) and 5-fluorouracil (5FU).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Prognosis; Survival Rate; Taxoids | 2004 |
[Evaluation of a combination chemotherapy with docetaxel and nedaplatin for patients with oral squamous cell carcinomas].
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Taxoids | 2005 |
Hyperselective intra-arterial preoperative chemotherapy in patients with squamous cell carcinoma of the oral cavity: preliminary results.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Magnetic Resonance Imaging; Male; Middle Aged; Mouth Neoplasms; Taxoids; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
A single-institute phase I/II trial combining nedaplatin dose escalation with a fixed dose of docetaxel for induction chemotherapy of oral squamous cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mouth Neoplasms; Neutropenia; Organoplatinum Compounds; Remission Induction; Taxoids | 2008 |
Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Cranial Irradiation; Docetaxel; Dose Fractionation, Radiation; Drug Tolerance; Feasibility Studies; Female; Humans; Injections, Intra-Arterial; Lymph Node Excision; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Recurrence, Local; Neoplasm Staging; Oropharyngeal Neoplasms; Paclitaxel; Patient Compliance; Pilot Projects; Prognosis; Radiotherapy, Adjuvant; Radiotherapy, Conformal; Survival Analysis; Taxoids | 2002 |
47 other study(ies) available for docetaxel anhydrous and Mouth Neoplasms
| Article | Year |
|---|---|
Assessment of neoadjuvant chemotherapy with docetaxel, cisplatin, and fluorouracil in patients with oral cavity cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Taxoids | 2023 |
Evaluation of a docetaxel-cisplatin-fluorouracil-Au complex in human oral carcinoma cell line.
Topics: Carcinoma, Squamous Cell; Cell Line; Cisplatin; Docetaxel; Fluorouracil; Gold; Humans; Metal Nanoparticles; Mouth Neoplasms; Taxoids | 2023 |
Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tongue Neoplasms | 2023 |
Concurrent chemoradiotherapy with intravenous cisplatin and docetaxel for advanced oral cancer.
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Docetaxel; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Treatment Outcome | 2019 |
Preoperative intra-arterial chemotherapy with docetaxel, cisplatin, and peplomycin combined with intravenous chemotherapy using 5-fluorouracil for oral squamous cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Fluorouracil; Humans; Mouth Neoplasms; Neoplasm Recurrence, Local; Peplomycin; Taxoids | 2020 |
Open label, Non-randomized, Interventional Study to Evaluate Response Rate After Induction Therapy with Docetaxel and Cisplatin in Locally Advanced Squamous Cell Carcinoma of Oral Cavity.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Remission Induction | 2020 |
MiR-92b as a marker for TPF induced chemotherapy response prediction and prognosis evaluation in with advanced oral squamous cell carcinoma patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Down-Regulation; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Logistic Models; Male; MicroRNAs; Mouth Neoplasms; Multivariate Analysis; Neoplasm Staging; Prognosis; Proportional Hazards Models; Up-Regulation | 2020 |
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy vs chemoradiotherapy alone as treatment of unresectable head and neck cancer: follow-up of the Spanish Head and Neck Cancer Group (TTCC) 2503 Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Clinical Trials, Phase III as Topic; Confidence Intervals; Docetaxel; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Induction Chemotherapy; Intention to Treat Analysis; Laryngeal Neoplasms; Mouth Neoplasms; Progression-Free Survival; Randomized Controlled Trials as Topic; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Tumor Burden | 2021 |
Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5-fluorouracil combination induction chemotherapy in oral squamous cell carcinoma.
Topics: Annexin A1; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2021 |
Effects of miR-224-5p-enhanced downregulation of pannexin-1 on docetaxel-induced apoptosis in amoeboid-like CD44
Topics: Amoeba; Apoptosis; Carcinoma, Squamous Cell; Connexins; Docetaxel; Down-Regulation; Humans; Hyaluronan Receptors; MicroRNAs; Mouth Neoplasms; Nerve Tissue Proteins | 2021 |
Influence of a dosing-time on toxicities induced by docetaxel, cisplatin and 5-fluorouracil in patients with oral squamous cell carcinoma; a cross-over pilot study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Circadian Rhythm; Cisplatin; Cross-Over Studies; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Pilot Projects; Time Factors; Treatment Outcome; Young Adult | 2018 |
Synthesis and in vitro studies of PLGA-DTX nanoconjugate as potential drug delivery vehicle for oral cancer.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Docetaxel; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Mouth Neoplasms; Nanoconjugates; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Taxoids | 2018 |
Thermochemoradiotherapy Using Superselective Intra-arterial Infusion for Patients With Oral Cancer With Cervical Lymph Node Metastases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradiotherapy; Combined Modality Therapy; Docetaxel; Female; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Staging | 2019 |
[Effect of silencing LASP1 on biological behaviors of oral squamous cell carcinoma cells and IC50 of three anti-tumor drugs].
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytoskeletal Proteins; Docetaxel; Drug Resistance, Neoplasm; Humans; Inhibitory Concentration 50; LIM Domain Proteins; Mice; Mice, Nude; Mouth Neoplasms; Neoplasm Invasiveness | 2019 |
Elevated cyclin D1 expression is predictive for a benefit from TPF induction chemotherapy in oral squamous cell carcinoma patients with advanced nodal disease.
Topics: Aged; Apoptosis; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclin D1; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Prognosis; Taxoids | 2013 |
The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck Dissection; Neoplasm Recurrence, Local; Neoplasm Staging; Radiotherapy, Adjuvant; Survival Rate; Taxoids; Young Adult | 2013 |
Sequential therapy of advanced buccal mucosa squamous cell carcinoma: three-year outcome.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymph Node Excision; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Prognosis; Retrospective Studies; Sex Factors; Taxoids | 2014 |
Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Organ Sparing Treatments; Remission Induction; Survival Rate; Taxoids | 2014 |
Effects of D-allose in combination with docetaxel in human head and neck cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Docetaxel; Glucose; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Taxoids | 2014 |
Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Pharyngeal Neoplasms; Retrospective Studies; Salvage Therapy; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
Role of induction chemotherapy for N3 head and neck squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Case-Control Studies; Chemoradiotherapy; Cisplatin; Cohort Studies; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Induction Chemotherapy; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pharyngeal Neoplasms; Radiotherapy; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2015 |
Lactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinoma.
Topics: Aged; Apoptosis; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Combinations; Drug Resistance, Neoplasm; Energy Metabolism; Female; Fluorouracil; G2 Phase Cell Cycle Checkpoints; Gene Deletion; Gene Expression; Humans; Isoenzymes; L-Lactate Dehydrogenase; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Prognosis; Survival Analysis; Taxoids; Treatment Outcome | 2015 |
Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Cisplatin; Diffusion Magnetic Resonance Imaging; Docetaxel; Female; Fluorouracil; Forecasting; Head and Neck Neoplasms; Humans; Image Processing, Computer-Assisted; Induction Chemotherapy; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Pharyngeal Neoplasms; Remission Induction; Retrospective Studies; Sensitivity and Specificity; Taxoids; Tumor Burden | 2015 |
Neoadjuvant Chemotherapy in Technically Unresectable Oral Cancers: Does Human Papillomavirus Make a Difference?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cohort Studies; Docetaxel; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Papillomaviridae; Papillomavirus Infections; Prognosis; Survival Rate; Taxoids; Young Adult | 2015 |
[Clinical Investigation of the Effects of Filgrastim BS1 on Neutropenia Following Oral Cancer Chemotherapy (TPF Therapy)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Male; Mouth Neoplasms; Neoplasm Staging; Neutropenia; Recombinant Proteins; Taxoids; Treatment Outcome | 2015 |
High expression of stathmin 1 is a strong prognostic marker in oral squamous cell carcinoma patients treated by docetaxel-containing regimens.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Docetaxel; Female; Gene Expression; Humans; Immunohistochemistry; Male; Middle Aged; Mouth Neoplasms; Multivariate Analysis; Neoplasm Staging; Prognosis; Stathmin; Survival Analysis; Taxoids; Treatment Outcome | 2017 |
[The Safety of Super-Selective Intra-Arterial Infusion Chemotherapy for Induction with Docetaxel, Cisplatin, and 5-Fluorouracil for Oral Cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Induction Chemotherapy; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Retrospective Studies; Taxoids | 2015 |
Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Cisplatin; Cohort Studies; Computed Tomography Angiography; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Head and Neck Neoplasms; Humans; Imaging, Three-Dimensional; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Male; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Prognosis; Proton Therapy; Retrospective Studies; Risk Assessment; Squamous Cell Carcinoma of Head and Neck; Statistics, Nonparametric; Survival Analysis; Taxoids; Treatment Outcome | 2016 |
Optimizing particle size of docetaxel-loaded micelles for enhanced treatment of oral epidermoid carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Docetaxel; Drug Delivery Systems; Humans; Mice; Micelles; Mouth Neoplasms; Particle Size; Polyethylene Glycols; Taxoids | 2016 |
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cytokines; Docetaxel; Dose Fractionation, Radiation; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Interleukin-1beta; Interleukin-6; Laryngeal Neoplasms; Mouth Neoplasms; Nasopharyngeal Neoplasms; Oropharyngeal Neoplasms; Prospective Studies; Radiotherapy, Intensity-Modulated; Saliva; Severity of Illness Index; Stomatitis; Taxoids; Time Factors; Tumor Necrosis Factor-alpha | 2016 |
Docetaxel-cisplatin-radiotherapy in adenoid cystic carcinoma with high-grade transformation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Magnetic Resonance Imaging; Maxillary Sinus Neoplasms; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Radiotherapy, Conformal; Taxoids; Tomography, X-Ray Computed | 2009 |
Superselective intra-arterial chemoradiotherapy with docetaxel-nedaplatin for advanced oral cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Therapy; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Mucositis; Organoplatinum Compounds; Prognosis; Quality of Life; Survival Rate; Taxoids; Treatment Outcome | 2010 |
[Docetaxel as a component in the combined therapy of locally advanced squamous cell carcinoma of the glottis and oral cavity].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Glottis; Humans; Kaplan-Meier Estimate; Laryngeal Neoplasms; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Platinum Compounds; Radiotherapy, Adjuvant; Taxoids; Treatment Outcome | 2010 |
[Evaluation of combination chemotherapy with oral S-1 administration followed by docetaxel by superselective intra-arterial infusion for patients with oral squamous cell carcinomas].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cerebral Infarction; Docetaxel; Drug Combinations; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Neutropenia; Oxonic Acid; Taxoids; Tegafur | 2011 |
[A review of toxicity superselective intra-arterial concurrent chemoradiotherapy(SIACC)for oral cancer].
Topics: Adult; Aged; Aged, 80 and over; Chemoradiotherapy; Cisplatin; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Leukopenia; Male; Middle Aged; Mouth Neoplasms; Taxoids | 2011 |
Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Catheter Ablation; Cerebral Arteries; Chemoradiotherapy; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Hyperthermia, Induced; Infusions, Intra-Arterial; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neck Dissection; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Taxoids; Temporal Arteries | 2012 |
Antitumor efficacy of sequential treatment with docetaxel and 5-fluorouracil against human oral cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dihydrouracil Dehydrogenase (NADP); Docetaxel; Down-Regulation; Fluorouracil; Humans; Mice; Mice, Nude; Mouth Neoplasms; Orotate Phosphoribosyltransferase; Taxoids; Thymidylate Synthase; Up-Regulation; Xenograft Model Antitumor Assays | 2012 |
γ-tocotrienol enhances the chemosensitivity of human oral cancer cells to docetaxel through the downregulation of the expression of NF-κB-regulated anti-apoptotic gene products.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Caspase 3; Cell Nucleus; Cell Proliferation; Chromans; Cytoplasm; Docetaxel; Down-Regulation; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Humans; Mouth Neoplasms; NF-kappa B; Peptide Library; Poly(ADP-ribose) Polymerases; Taxoids; Tumor Cells, Cultured; Vitamin E | 2013 |
[A clinical study of neoadjuvant radiochemotherapy with docetaxel and cisplatin for oral cancers].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Neutropenia; Radiotherapy Dosage; Radiotherapy, Adjuvant; Stomatitis; Taxoids | 2003 |
Involvement of NF-kappaB and mitochondrial pathways in docetaxel-induced apoptosis of human oral squamous cell carcinoma.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase 8; Caspases; Cytochromes c; Docetaxel; Humans; Membrane Potentials; Mitochondria; Mouth Neoplasms; NF-kappa B; Reactive Oxygen Species; Taxoids; Tumor Cells, Cultured | 2005 |
Role of O6-methylguanine-DNA methyltransferase and effect of O6-benzylguanine on the anti-tumor activity of cis-diaminedichloroplatinum(II) in oral cancer cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cisplatin; DNA Repair; Docetaxel; Drug Resistance, Neoplasm; Guanine; Humans; Methylnitronitrosoguanidine; Mouth Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Taxoids | 2005 |
Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Proteins; Cell Division; Docetaxel; Drug Resistance, Neoplasm; Female; G2 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Microtubules; Middle Aged; Mouth Neoplasms; Neoplasm Proteins; Neoplasms, Squamous Cell; Paclitaxel; Poly-ADP-Ribose Binding Proteins; RNA, Small Interfering; Taxoids; Ubiquitin-Protein Ligases | 2005 |
Adenocarcinoma ex pleomorphic adenoma of the head and neck: Report of five cases.
Topics: Adenoma, Pleomorphic; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Female; Fluorouracil; Humans; Male; Middle Aged; Mouth Neoplasms; Nasopharyngeal Neoplasms; Neoadjuvant Therapy; Organoplatinum Compounds; Palate; Parotid Gland; Retrospective Studies; Taxoids | 2006 |
Maximized combined modality treatment of an unselected population of oral and oropharyngeal cancer patients. Final results of a pilot study compared with a treatment-dependent prognosis index.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Docetaxel; Epidemiologic Methods; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Squamous Cell; Oropharyngeal Neoplasms; Prognosis; Recurrence; Survival Rate; Taxoids; Treatment Outcome; Treatment Refusal | 2006 |
[Organ-preserving treatment in inoperable patients with primary oral and oropharyngeal carcinoma: chances and limitations].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Oropharyngeal Neoplasms; Palliative Care; Radiotherapy, Adjuvant; Retreatment; Survival Rate; Taxoids | 2006 |
[Evaluation of combination chemotherapy with S-1 and docetaxel for patients with oral squamous cell carcinomas].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Docetaxel; Drug Combinations; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Mouth Neoplasms; Neoadjuvant Therapy; Oxonic Acid; Taxoids; Tegafur | 2007 |
[Experimental chemotherapy of xenotransplanted oral squamous epithelial carcinoma: effectiveness of docetaxel (taxotere) in the nude mouse model].
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Cell Division; Cell Survival; Docetaxel; Humans; Male; Mice; Mice, Nude; Mouth Mucosa; Mouth Neoplasms; Neoplasm Transplantation; Paclitaxel; Taxoids; Transplantation, Heterologous; Tumor Cells, Cultured | 1999 |